Results 51 to 60 of about 4,990,258 (337)

USING TAXES AS ECONOMIC – FINANCIAL INSTRUMENTS [PDF]

open access: yesScientific Papers Series : Management, Economic Engineering in Agriculture and Rural Development, 2016
The paper aimed to analyze the use of taxes as an economic-financial instrument in Romania, comparatively with other EU states. The main aspects approached have been: total taxes, direct and indirect taxes, contributions to social insurance, profit tax ...
Daniela SIMTION
doaj  

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Financial instability from local market measures

open access: yes, 2012
We study the emergence of instabilities in a stylized model of a financial market, when different market actors calculate prices according to different (local) market measures.
Albanese C   +12 more
core   +1 more source

Financial instruments fair value accounting for (not against) the banking industry [PDF]

open access: yes, 2003
The paper analyses the effects of three sets of accounting rules for financial instruments - Old IAS before IAS 39 became effective, Current IAS or US GAAP, and the Full Fair Value (FFV) model proposed by the Joint Working Group (JWG) - on the financial ...
Gebhardt, Günther   +2 more
core   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

open access: yesMolecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg   +43 more
wiley   +1 more source

Current Issues Regarding the Recording in Accounting of the Financial Instruments for Financing the Activity of the Entities [PDF]

open access: yesOvidius University Annals: Economic Sciences Series, 2021
The use of financial instruments is a relatively small phenomenon in the context of the current Romanian economy. However, we can see an increase in the use of financial instruments to finance the current and future activities of entities in the national
Traian Cristin Nicolae
doaj  

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Financial Instruments: the Essence, Diversity and Role in the Process of Modernization of the Electric Power Sector [PDF]

open access: yesProblemi Ekonomiki, 2017
The aim of the article is to clarify the methodological basis for further research concerning analysis of the existing practices and development of proposals on using financial instruments for the modernization of the Ukrainian electric power sector, in ...
Abakumenko Olha V., Lukiashko Pavlo O.
doaj  

Financial Instruments of the Socially Responsible Economy

open access: yes, 2017
Taking into account its specific character, each country forms its own model of the social policy. Four models of the social policy are used in the countries of the European Community: social-democratic (Scandinavian), corporate (continental), and ...
I. Denisova   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy